DEF 14AThe Ballot
BIOCRYST PHARMACEUTICALS INC files DEF 14A
Filed Apr 25, 2022 · 4y ago · Accession 0001140361-22-015743
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Ticker
- BCRX
- CIK
- 882796
- Form type
- DEF 14A
- Filing date
- Apr 25, 2022
- Report date
- Jun 7, 2022
- Document
- ny20002713x1_def14a.htm
- Size
- 3.0 MB